QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=1695B1BA9C79AC59971D567D8DAC638A;jsessionid=9BD19521C9C4C9A626F4F4D53253B25D;jsessionid=F02703FF10E636A808B9AAE1F4BA27D7;jsessionid=9C7AD874E06E486E5050F8D1E18B7265 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=1695B1BA9C79AC59971D567D8DAC638A;jsessionid=9BD19521C9C4C9A626F4F4D53253B25D;jsessionid=F02703FF10E636A808B9AAE1F4BA27D7;jsessionid=9C7AD874E06E486E5050F8D1E18B7265